Robert M. VanHimbergen, Executive Vice President and CFO of Elanco Animal Health Incorporated, filed a statement of changes in beneficial ownership on August 25, 2026, reporting the acquisition of deferred stock units on August 21, 2026.
Key Highlights
- Reporting person: Robert M. VanHimbergen, EVP and CFO of Elanco Animal Health Incorporated
- Transaction date: August 21, 2026, with the filing submitted August 25, 2026
- Units acquired: 8.2194 deferred stock units under transaction code A (acquired)
- Price per unit: $23.97, with each deferred stock unit representing the right to receive one share of common stock or cash equivalent
- Post-transaction holdings: 141.8242 deferred stock units held directly following the reported transaction
- Settlement terms: Units settle in cash or shares following termination of employment or during a specified future year per the Executive Deferral and Stock Match Plan
VanHimbergen's Deferred Unit Acquisition Under Elanco's Executive Deferral Plan
According to the filing, Robert M. VanHimbergen, who serves as Executive Vice President and Chief Financial Officer of Elanco Animal Health Incorporated (NYSE:ELAN), acquired 8.2194 deferred stock units on August 21, 2026. The transaction was recorded under Table II of the filing, which covers derivative securities. Elanco Animal Health is an animal health company headquartered at 450 Elanco Circle, Indianapolis, Indiana 46221.
The filing discloses that each deferred stock unit "represents the right to receive one share of Company common stock or the cash equivalent." The units were acquired at a price of $23.97 and are governed by Elanco's Executive Deferral and Stock Match Plan. Per the filing's explanation of responses, these deferred stock units "settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan." No exercisable date or expiration date was specified in the filing for these units.
Following the reported transaction, VanHimbergen directly holds 141.8242 deferred stock units, according to the filing. The ownership form is listed as direct. No non-derivative securities transactions were reported in Table I of this filing. The document was signed by Amy C. Seidel as Attorney-in-Fact for Robert M. VanHimbergen on August 25, 2026.
What Was Disclosed
The filing reported the acquisition of 8.2194 deferred stock units by Elanco Animal Health's CFO on August 21, 2026, at $23.97 per unit, bringing his total directly held deferred stock units to 141.8242 under the company's Executive Deferral and Stock Match Plan.



Please wait processing your request...